STK11 Mutations Correlate with Poor Prognosis for Advanced NSCLC Treated with First-Line Immunotherapy or Chemo-Immunotherapy According to KRAS, TP53, KEAP1, and SMARCA4 Status

Andrea De Giglio,Dario De Biase, Valentina Favorito,Thais Maloberti,Alessandro Di Federico, Federico Zacchini, Giulia Venturi, Claudia Parisi, Filippo Gustavo Dall'Olio, Ilaria Ricciotti, Ambrogio Gagliano,Barbara Melotti,Francesca Sperandi,Annalisa Altimari,Elisa Gruppioni, Giovanni Tallini,Francesco Gelsomino, Lorenzo Montanaro,Gruppioni Andrea Ardizzoni

LUNG CANCER（2025）

Cited 0|Views13

Key words

NSCLC,Immunotherapy,STK11,Prognosis

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined